Abstract
Purpose
To evaluate the efficacy and safety of drug-coated balloon angioplasty compared to conventional balloon angioplasty in the treatment of dysfunctional arteriovenous grafts.
Materials and Methods
This prospective, multicenter, randomized clinical trial enrolled 190 patients with venous anastomotic stenosis in arteriovenous grafts at five participating hospitals. During pre-dilation, 4 patients dropped out due to ruptures requiring further treatment (n = 2) and residual stenosis of > 30% (n = 2). On successful pre-dilation with a 7 mm conventional balloon, patients were randomized to undergo either a 7 mm drug-coated balloon (n = 94) or conventional balloon angioplasty (n = 92).
The primary out-come measure was target lesion primary patency at 3 and 6 months. The secondary out-come measures included target lesion primary patency at 12 months and access circuit primary patency at 6 and 12 months, clinical and technical success rates, and 12-month mortality differences between the groups.
Results
The target lesion primary patency and access circuit patency rates at 3 and 6 months were significantly higher in drug-coated balloon angioplasty group as compared to conventional balloon angioplasty group. The technical and clinical success rates were 100% for both the groups. As a procedure-related complication, anastomotic site rupture occurred during pre-dilation in 4 cases. The number of deaths during the 12-month follow-up was one for each group. The number of early thrombotic events (at < 3 months) was significantly higher in the drug-coated balloon group (p = 0.002).
Conclusion
Drug-coated balloon angioplasty was more effective and safer for the treatment of dysfunctional arteriovenous grafts compared to conventional balloon angioplasty.
Similar content being viewed by others
References
Wu CC, Lin MC, Pu SY, Tsai KC, Wen SC. Comparison of cutting balloon versus high-pressure balloon angioplasty for resistant venous stenoses of native hemodialysis fistulas. J Vasc Interv Radiol. 2008;19:877–83. https://doi.org/10.1016/j.jvir.2008.02.016.
Glanz S, Gordon DH, Butt KM, Hong J, Lipkowitz GS. The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas. Ann Surg. 1987;206:777–81. https://doi.org/10.1097/00000658-198712000-00015.
Trerotola SO, Stavropoulos SW, Shlansky-Goldberg R, Tuite CM, Kobrin S, Rudnick MR. Hemodialysis-related venous stenosis: treatment with ultrahigh-pressure angioplasty balloons. Radiology. 2004;231:259–62. https://doi.org/10.1148/radiol.2311030949.
Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75:s1–164. https://doi.org/10.1053/j.ajkd.2021.02.002.
Maleux G, Mijnsbrugge WV, Henroteaux D, Laenen A, Cornelissen S, Claes K, et al. Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae. J Vasc Interv Radiol. 2018;29:470–5. https://doi.org/10.1016/j.jvir.2017.10.023.
Kennedy SA, Mafeld S, Baerlocher MO, Jaberi A, Rajan DK. Drug-Coated balloon angioplasty in hemodialysis circuits: a systematic review and meta-analysis. J Vasc Interv Radiol. 2019;30:483–94. https://doi.org/10.1016/j.jvir.2019.01.012.
Lookstein RA, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S, et al. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N Engl J Med. 2020;383:733–42. https://doi.org/10.1056/nejmoa1914617.
Lia MT, Lee CP, Lin TT, Jong CB, Chen TY, Lin L, et al. A randomized controlled trial of drug-coated balloon angioplasty in venous anastomotic stenosis of dialysis arteriovenous grafts. J Vasc Surg. 2020;71:1994–2003. https://doi.org/10.1016/j.jvs.2019.07.090.
Gray RJ, Sacks D, Martin LG, Trerotola SO. Reporting standards for percutaneous interventions in dialysis access. J Vasc Interv Radiol. 2003;14:S433–42. https://doi.org/10.1097/01.rvi.0000094618.61428.58.
Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, et al. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 2010;362:494–503. https://doi.org/10.1056/nejmoa0902045.
Vesely T, DaVanzo W, Behrend T, Dwyer A, Aruny J. Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts. J Vasc Surg. 2016;64:1400–10. https://doi.org/10.1016/j.jvs.2016.04.035.
Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther. 2012;19:263–72. https://doi.org/10.1583/11-3690.1.
Kitrou PM, Spiliopoulos S, Katsanos K, Papachristou E, Siablis D, Karnabatidis D. Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. J Vasc Interv Radiol. 2015;26:348–54. https://doi.org/10.1016/j.jvir.2014.11.003.
Lai CC, Fang HC, Tseng CJ, Liu CP, Mar GY. Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study. J Vasc Interv Radiol. 2014;25:535–41. https://doi.org/10.1016/j.jvir.2013.12.014.
Rokoszak V, Syed MH, Salata K, Greco E, de Mestral CD, Hussain MA, et al. A systematic review and meta-analysis of plain versus drug-eluting balloon angioplasty in the treatment of juxta-anastomotic hemodialysis arteriovenous fistula stenosis. J Vasc Surg. 2020;71:1046–54. https://doi.org/10.1016/j.jvs.2019.07.075.
Trerotola SO, Lawson J, Roy-Chaudhury P, Saad TF. Drug coated balloon angioplasty in failing av fistulas: a randomized controlled trial. Clin J Am Soc Nephrol. 2018;13:1215–24. https://doi.org/10.2215/cjn.14231217.
Liao MT, Chen MK, Hsieh MY, Yeh NL, Chien KL, Lin CC, et al. Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2020;15:e0231463. https://doi.org/10.1371/journal.pone.0231463.
Luo C, Liang M, Liu Y, Zheng D, He Q, Jin J. Paclitaxel coated balloon versus conventional balloon angioplasty in dysfunctional dialysis arteriovenous fistula: a systematic review and meta-analysis of randomized controlled trials. Ren Fail. 2022;44:155–70. https://doi.org/10.1080/0886022x.2022.2029487.
Trerotola SO, Saad TF, Roy-Chaudhury P, Lutonix AV. Clinical trial investigators. The lutonix AV randomized trial of paclitaxel-coated balloons in arteriovenous fistula stenosis: 2-year results and subgroup analysis. J Vasc Interv Radiol. 2020;31:1-14.e5. https://doi.org/10.1016/j.jvir.2019.08.035.
Lee HS, Kang J, Park KW, Ki YJ, Chang M, Han JK, et al. Procedural optimization of drug-coated balloons in the treatment of coronary artery disease. Catheter Cardiovasc Interv. 2021;98:E43–52. https://doi.org/10.1002/ccd.29492.
Dinh K, Limmer AM, Paravastu SCV, Thomas SD, Bennett MH, Holden A, et al. Mortality after paclitaxel-coated device use in dialysis access: a systematic review and meta-analysis. J Endovasc Ther. 2019;26:600–12. https://doi.org/10.1177/1526602819872154.
van Werkum JW, Heestermans AA, de Korte FI, Kelder JC, Suttorp MJ, Rensing BJ, et al. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation. 2009;119:828–34. https://doi.org/10.1161/circulationaha.108.799403.
Kim SM, Ko HK, Noh M, Ko GY, Kim MJ, Kwon TW, et al. Factors affecting patency following successful percutaneous intervention for dysfunctional hemodialysis vascular access. Ann Vasc Surg. 2018;47:54–61. https://doi.org/10.1016/j.avsg.2017.08.003.
Zheng Q, Xie B, Xie X, Zhang W, Hou J, Feng Z, et al. Predictors associated with early and late stenosis of arteriovenous fistulas and grafts after percutaneous transluminal angiography. Ann Transl Med. 2021;9:132.
Neuen BL, Gunnarsson R, Baer RA, Tosenovsky P, Green SJ, Golledge J, et al. Factors associated with patency following angioplasty of hemodialysis fistula. J Vasc Interv Radiol. 2014;25:1419–26. https://doi.org/10.1016/j-jvir.2014.05.020.
Acknowledgements
Authors thank SH Kwon and HJ Noh (nephrologists) for their help in the follow-up of the patients. We also thank SH Park for statistical advice and support.
Author information
Authors and Affiliations
Contributions
DE Goo and SW Park were in charge of the study conception and design. Material preparation and data collection were performed by DE Goo, YJ Kim, SW park, HJ Cheon, YD Won, and SB Yang. The first manuscript was written by DE Goo and SW Park, and all authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
This study was financially supported by Medtronic.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Goo, D.E., Kim, Y.J., Park, S.W. et al. A Prospective Multicenter Randomized Controlled Trial for Comparing Drug-Coated and Conventional Balloon Angioplasty in Venous Anastomotic Stenosis of Hemodialysis Arteriovenous Grafts. Cardiovasc Intervent Radiol 47, 36–44 (2024). https://doi.org/10.1007/s00270-023-03536-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-023-03536-5